 This is a study involving treatment for alcohol dependence alcoholism. The study will combine motivational enhancement therapy and cognitive behavioral therapy combined behavioral intervention, or CBI and tests the benefits of continueddiscontinued treatment with naltrexone in a randomized placebo-controlled trial. CBI may have advantages in motivating patients to greater medication adherence and may address psychosocial factors that may limit the effects of naltrexone. 